Asylia Therapeutics is a biotechnology company focused on developing innovative therapeutic solutions. The company aims to address unmet medical needs through advanced research and development of novel drug candidates. While detailed public information is limited, Asylia Therapeutics is positioned within the biotech sector, seeking partnerships and investment to advance its pipeline.
Asylia Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Therapeutics, Health, and Innovation.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
Show this score on your site.
It updates itself when the score changes. Paste this where you link to your API docs:
<a href="https://apis.io/providers/asylia-therapeutics/"><img src="https://apis.io/badge/asylia-therapeutics/card.svg" alt="Asylia Therapeutics on APIs.io — Kin Score by API Evangelist"></a>
Other styles, a README pill and a shields.io endpoint are on the badge page.
aid: asylia-therapeutics
name: Asylia Therapeutics
description: Asylia Therapeutics is a biotechnology company focused on developing innovative therapeutic solutions. The company
aims to address unmet medical needs through advanced research and development of novel drug candidates. While detailed public
information is limited, Asylia Therapeutics is positioned within the biotech sector, seeking partnerships and investment
to advance its pipeline.
url: https://raw.githubusercontent.com/api-evangelist/asylia-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment pass 2026-09-26 (modular-v1; was harvest)
specificationVersion: '0.20'
created: '2026-09-26'
modified: '2026-09-26'
tags:
- Company
- Biotechnology
- Therapeutics
- Health
- Innovation
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: Hosts
url: hosts/asylia-therapeutics-hosts.yml
- type: Vendors
url: vendors/asylia-therapeutics-vendors.yml
- type: DomainSecurity
url: security/asylia-therapeutics-domain-security.yml
- type: Website
url: https://www.nasdaqprivatemarket.com/
apis: []
x-coverage:
state: none
reason: no-developer-program
detail: Company listing on Nasdaq Private Market provides no developer program or API documentation.
evidence:
- url: https://www.nasdaqprivatemarket.com
status: 200
checked: '2026-09-26'
x-enrichment:
date: '2026-09-26'
status: minimal
artifacts_added: 2
pass: modular-v1
engine: identity=local,contract=local,surfaces=local,docs=local
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.